1. Case report of a lymphoepithelioma-like hepatocellular carcinoma with prominent lymphoplasmacytic infiltration
- Author
-
Hirotsugu Noguchi, Natsumi Noguchi, Tetsuya Idichi, Yota Kawasaki, Mari Kirishima, Takashi Tasaki, Ikumi Kitazono, Michiko Horinouchi, Tsubasa Hiraki, Michiyo Higashi, and Akihide Tanimoto
- Subjects
Lymphoepithelioma-like carcinoma ,Hepatocellular carcinoma ,Plasma cell ,Programmed death ligand 1 ,Pathology ,RB1-214 - Abstract
Lymphoepithelioma-like carcinoma (LELC) of the liver is extremely rare, and lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is an uncommon variant form of HCC, exhibiting relatively good prognosis compared to conventional HCC. LELC is defined as a tumour composed of undifferentiated epithelial cells with densely infiltrating lymphoid stroma. LEL-HCC represents a unique immune response against tumour cells, which may contribute to the superior clinical outcomes. However, the exact aetiology remains unknown. We report a case of a 76-year-old man with a prior hepatitis B virus infection. A 20 mm tumour was detected in the liver. Microscopically, the tumour displayed characteristics of poorly differentiated HCC with a dense lymphocytic and plasma cell infiltration and was diagnosed as LEL-HCC. We describe a unique pathological finding with immunohistochemical data demonstrating T-cell dominant lymphocytic and polyclonal plasma cell infiltration, along with programmed death ligand 1 expression in the tumour cells and lymphocytes.
- Published
- 2020
- Full Text
- View/download PDF